Jorge L. Alió: Power List Perspectives
August 15, 2025
Our Power Lister winners explore the major trends in their field, and the seismic impact AI and machine learning is having on the profession
2 min read
False
August 15, 2025
Our Power Lister winners explore the major trends in their field, and the seismic impact AI and machine learning is having on the profession
2 min read
By Alun Evans
August 14, 2025
New Eye study indicates water sports participants could be an overlooked risk group for AMD
2 min read
August 12, 2025
EXN407 is the first topical SRPK1 inhibitor to demonstrate safety and efficacy as a monotherapy for non-proliferative diabetic retinopathy (NPDR) and diabetic macular edema
1 min read
By Alun Evans
August 8, 2025
The Ophthalmologist brings you the top news stories and studies of the week
3 min read
August 6, 2025
One of the fastest enrolling phase III pivotal programs for wet AMD
3 min read
August 5, 2025
Novel biomarker could sharpen risk assessment for retinal detachment and retinal breaks
1 min read
By Alun Evans
July 29, 2025
Could photobiomodulation really become a mainstream treatment alternative for dry age-related macular degeneration?
2 min read
By Julian Upton
July 25, 2025
Our 2025 Power Lister winners take a look at current trends in their subspecialties
3 min read
By Alun Evans
July 25, 2025
The Ophthalmologist brings you the top news stories and studies of the week
4 min read
False
False
False
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: